Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

China Arrests 135 for Illegally Buying, Selling Vaccines

By AP | May 23, 2016

BEIJING (AP) — China has arrested 135 people in 22 provinces for illegally buying and selling vaccines, in the latest scandal shaking the Chinese public’s confidence in vaccine safety.

In an online statement Friday, the national prosecuting office said arrest warrants were issued for 125 people for running vaccine businesses without license.

It said 15 of them have been formally indicted, and two were found guilty. Ten health officials were arrested for on-duty negligence.

The accused health officials had worked at local public health centers and knowingly bought the illegal vaccines and used them on people, the prosecuting office said.

The massive investigation followed a case in March when a doctor in the eastern province of Shandong were found to have sold 2 million doses of improperly stored or expired vaccines. Media reports said she stored the vaccines at room temperature, instead of keeping them refrigerated as required.

Vaccines not stored and managed properly can lose their effectiveness and may not protect people being inoculated. The vaccines in the March case included those for hepatitis B, rabies, mumps and Japanese encephalitis.

The scandal drew criticism from people upset with persistent food and drug safety issues in the country. Beijing quickly ordered an investigation to crack down on illegal businesses of vaccines.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50